News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,774 Results
Type
Article (2700)
Company Profile (25)
Press Release (39048)
Multimedia
Podcasts (16)
Webinars (2)
Section
Business (16032)
Career Advice (78)
Deals (2162)
Drug Delivery (11)
Drug Development (4197)
Employer Resources (10)
FDA (457)
Job Trends (790)
News (20413)
Policy (1057)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (147)
ADA (4)
Allergies (8)
Alliances (3488)
ALS (9)
Alzheimer's disease (80)
Antibody-drug conjugate (ADC) (60)
Approvals (474)
Artificial intelligence (61)
ASCO (16)
Autoimmune disease (41)
Automation (6)
Bankruptcy (13)
Belgium (1)
Best Places to Work (476)
BIO (12)
Biologics (1)
BIOSECURE Act (2)
Biosimilars (26)
BioSpace Insights (12)
Biotechnology (17)
Bispecific (1)
Bladder cancer (11)
Brain cancer (9)
Breast cancer (64)
Cancer (484)
Cardiovascular disease (17)
Career advice (67)
Career pathing (1)
CAR-T (55)
CDC (2)
CDMO (8)
Celiac Disease (1)
Cell therapy (119)
Cervical cancer (7)
Clinical research (3672)
Collaboration (280)
Commercialization (2)
Company closure (4)
Compensation (157)
Complete response letters (1)
COVID-19 (187)
CRISPR (13)
C-suite (206)
Cystic fibrosis (8)
Data (679)
Denatured (6)
Depression (12)
Dermatology (2)
Diabetes (25)
Diagnostics (515)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (59)
Drug pricing (10)
Duchenne muscular dystrophy (66)
Earnings (4777)
Editorial (6)
Employer branding (1)
Employer resources (8)
Events (6755)
Executive appointments (167)
FDA (676)
Fragile X (1)
Friedreich's ataxia (8)
Frontotemporal dementia (1)
Funding (252)
Gene editing (43)
Generative AI (3)
Gene therapy (82)
GLP-1 (82)
Government (164)
Guidances (25)
Healthcare (731)
Hematology (8)
HIV (3)
Huntington's disease (6)
IgA nephropathy (17)
Immunology and inflammation (45)
Immuno-oncology (21)
Indications (12)
Infectious disease (210)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (45)
Interviews (7)
IPO (1020)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (4)
Kidney cancer (13)
Kidney disease (7)
Labor market (13)
Layoffs (57)
Leadership (4)
Legal (213)
Licensing (6)
Liver cancer (7)
Longevity (7)
Lung cancer (48)
Lung diease (3)
Lymphoma (19)
Machine learning (5)
Management (4)
Manufacturing (97)
MASH (19)
Medical device (371)
Medtech (376)
Mergers & acquisitions (1279)
Metabolic disorders (108)
mRNA (20)
Multiple sclerosis (29)
Neurodegenerative disease (46)
Neuropsychiatric disorders (14)
Neuroscience (232)
NextGen: Class of 2026 (355)
Non-profit (160)
Now hiring (17)
Obesity (53)
Opinion (21)
Ovarian cancer (30)
Pain (41)
Pancreatic cancer (28)
Parkinson's disease (17)
Partnered (4)
Patents (78)
Patient recruitment (65)
Patient selection (2)
Peanut (1)
People (6103)
Pharmaceutical (2)
Phase 1 (1574)
Phase 2 (1803)
Phase 3 (979)
Pipeline (916)
Policy (17)
Postmarket research (30)
Preclinical (675)
Press Release (3)
Prostate cancer (9)
Psychedelics (5)
Radiopharmaceuticals (23)
Rare diseases (110)
Real estate (425)
Recruiting (5)
Regulatory (1029)
Reports (7)
Research institute (150)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (6)
RSV (3)
Schizophrenia (18)
Series A (64)
Series B (30)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (505)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (10)
Vaccines (76)
Venture capital (23)
Weight loss (29)
Women's health (28)
Worklife (1)
Date
Last 7 days (49)
Last 30 days (182)
Last 365 days (2424)
2026 (1886)
2025 (2442)
2024 (2594)
2023 (2865)
2022 (3767)
2021 (4056)
2020 (3489)
2019 (2072)
2018 (1555)
2017 (1800)
2016 (1621)
2015 (1831)
2014 (1368)
2013 (1185)
2012 (1392)
2011 (1328)
2010 (1175)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2038)
Australia (312)
California (2226)
Canada (344)
China (132)
Colorado (81)
Connecticut (23)
Delaware (16)
Europe (4232)
Florida (80)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (34)
India (7)
Indiana (78)
Japan (25)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (81)
Massachusetts (820)
Michigan (15)
Minnesota (35)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (185)
New York (124)
North Carolina (169)
Northern California (1152)
Ohio (66)
Oklahoma (2)
Oregon (7)
Pennsylvania (155)
Puerto Rico (1)
Rhode Island (4)
South America (41)
South Carolina (2)
Southern California (902)
Tennessee (6)
Texas (214)
United States (4482)
Utah (7)
Virginia (17)
Washington D.C. (4)
Washington State (118)
West Virginia (1)
Wisconsin (22)
41,774 Results for "hummingbird bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hummingbird Bioscience Appoints Dr. James Garner as President
September 15, 2026
·
3 min read
Press Releases
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
September 30, 2026
·
6 min read
Press Releases
Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards
July 14, 2026
·
4 min read
Press Releases
Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026
September 30, 2026
·
1 min read
Press Releases
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
January 6, 2026
·
2 min read
Press Releases
Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer
January 12, 2026
·
2 min read
Press Releases
Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR
June 2, 2026
·
2 min read
Press Releases
Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics
June 26, 2025
·
3 min read
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
1 of 4,178
Next
